Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ahmet Aydin

Concepts (135)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Penile Neoplasms
7
2025
45
3.700
 Why?
Urinary Bladder Neoplasms
7
2022
167
2.850
 Why?
Carcinoma, Squamous Cell
5
2021
332
1.820
 Why?
Carcinoma, Transitional Cell
3
2022
54
1.440
 Why?
Prostatic Neoplasms
3
2020
401
1.420
 Why?
Kidney Neoplasms
5
2021
181
1.410
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
89
1.330
 Why?
Carcinoma, Renal Cell
4
2021
112
0.930
 Why?
Pheochromocytoma
1
2023
34
0.810
 Why?
Immunotherapy
6
2021
266
0.800
 Why?
Adrenal Gland Neoplasms
1
2023
49
0.800
 Why?
Urothelium
1
2021
20
0.680
 Why?
BCG Vaccine
2
2020
16
0.660
 Why?
Neoadjuvant Therapy
5
2022
124
0.660
 Why?
Indocyanine Green
1
2020
29
0.650
 Why?
Cancer Vaccines
1
2021
79
0.640
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.640
 Why?
CD8-Positive T-Lymphocytes
1
2021
145
0.630
 Why?
Adjuvants, Immunologic
1
2020
52
0.620
 Why?
Anesthesia, Local
1
2019
18
0.600
 Why?
Edetic Acid
1
2019
14
0.600
 Why?
Tumor Suppressor Proteins
2
2021
130
0.600
 Why?
Male
24
2025
27435
0.600
 Why?
Patient Readmission
1
2021
251
0.590
 Why?
Testicular Neoplasms
4
2021
46
0.590
 Why?
Immunotherapy, Adoptive
1
2021
163
0.590
 Why?
Ureteral Neoplasms
1
2019
11
0.590
 Why?
Prostate-Specific Antigen
1
2019
43
0.590
 Why?
Papillomavirus Infections
1
2021
177
0.580
 Why?
Oligopeptides
1
2019
94
0.560
 Why?
Neoplasm Recurrence, Local
4
2021
647
0.530
 Why?
Humans
30
2025
53230
0.520
 Why?
Cystectomy
3
2022
52
0.510
 Why?
Arteriovenous Fistula
1
2016
28
0.490
 Why?
Neoplasms, Germ Cell and Embryonal
3
2021
21
0.440
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1043
0.420
 Why?
Retrospective Studies
9
2022
6819
0.400
 Why?
Lymphatic Metastasis
4
2021
211
0.390
 Why?
Middle Aged
11
2021
13419
0.390
 Why?
Aged
10
2021
10429
0.370
 Why?
Neoplasm Grading
4
2020
128
0.370
 Why?
Neoplasm Invasiveness
3
2022
281
0.350
 Why?
Tumor Microenvironment
3
2021
274
0.320
 Why?
Female
13
2023
28782
0.300
 Why?
Lymph Nodes
2
2021
252
0.290
 Why?
Treatment Outcome
7
2022
5595
0.260
 Why?
Prognosis
3
2020
2118
0.230
 Why?
Social Stigma
1
2025
52
0.230
 Why?
Neoplasm Metastasis
3
2021
237
0.220
 Why?
Postoperative Complications
3
2021
1099
0.210
 Why?
Quality of Life
2
2020
902
0.210
 Why?
Adrenalectomy
1
2023
31
0.210
 Why?
Early Detection of Cancer
1
2025
190
0.210
 Why?
Adrenal Glands
1
2023
38
0.200
 Why?
Adult
8
2023
14534
0.200
 Why?
Public Health
1
2025
231
0.200
 Why?
Neoplasm Staging
3
2021
774
0.190
 Why?
Deoxycytidine
1
2022
26
0.190
 Why?
Retroperitoneal Space
2
2021
26
0.180
 Why?
Aged, 80 and over
2
2021
3494
0.180
 Why?
Muscles
1
2022
110
0.180
 Why?
Cohort Studies
3
2021
1557
0.180
 Why?
Mycobacterium bovis
1
2021
11
0.170
 Why?
Antigens, Differentiation, Myelomonocytic
1
2021
38
0.170
 Why?
Lymph Node Excision
2
2021
132
0.170
 Why?
T-Lymphocytes
2
2020
321
0.170
 Why?
Aftercare
1
2021
73
0.170
 Why?
Teratoma
1
2021
22
0.170
 Why?
Interleukin-2
1
2021
69
0.170
 Why?
Reference Standards
1
2020
52
0.170
 Why?
Tomography, Emission-Computed
1
2020
53
0.160
 Why?
Fluorouracil
1
2020
59
0.160
 Why?
Cisplatin
1
2022
282
0.160
 Why?
Lymphocyte Activation
1
2021
163
0.160
 Why?
Recurrence
2
2019
694
0.160
 Why?
Carcinoma in Situ
1
2020
72
0.160
 Why?
Antigens, CD
1
2021
217
0.160
 Why?
Sentinel Lymph Node Biopsy
1
2020
119
0.160
 Why?
Survival Rate
2
2019
949
0.150
 Why?
Gallium Isotopes
1
2019
2
0.150
 Why?
Gallium Radioisotopes
1
2019
9
0.150
 Why?
Patient Discharge
1
2021
325
0.150
 Why?
Kidney Pelvis
1
2019
16
0.150
 Why?
Disease-Free Survival
1
2020
466
0.150
 Why?
Feasibility Studies
1
2020
411
0.140
 Why?
Genomics
1
2020
271
0.140
 Why?
Urologic Neoplasms
1
2018
12
0.140
 Why?
Papillomavirus Vaccines
1
2019
74
0.140
 Why?
Ureteral Obstruction
1
2019
62
0.140
 Why?
Carcinoma, Papillary
1
2018
50
0.140
 Why?
Antineoplastic Agents
3
2020
1232
0.130
 Why?
Genetic Predisposition to Disease
1
2020
533
0.130
 Why?
Cells, Cultured
1
2021
1569
0.130
 Why?
Biopsy
1
2019
600
0.130
 Why?
Cell Proliferation
1
2021
1031
0.130
 Why?
Renal Artery
1
2016
32
0.120
 Why?
Gene Expression Regulation, Neoplastic
1
2020
868
0.120
 Why?
Nephrectomy
1
2016
81
0.120
 Why?
Time Factors
2
2020
2991
0.120
 Why?
Urinary Tract Infections
1
2015
56
0.110
 Why?
Prospective Studies
1
2020
2411
0.110
 Why?
Laparoscopy
1
2016
180
0.110
 Why?
Kidney Failure, Chronic
1
2015
210
0.100
 Why?
Kidney Transplantation
1
2015
203
0.100
 Why?
Risk Factors
1
2019
4017
0.080
 Why?
Chemotherapy, Adjuvant
2
2020
122
0.080
 Why?
Kaplan-Meier Estimate
2
2021
487
0.080
 Why?
Follow-Up Studies
3
2020
2318
0.070
 Why?
Survival Analysis
2
2021
659
0.070
 Why?
T-Lymphocyte Subsets
1
2021
39
0.040
 Why?
Immune System
1
2021
41
0.040
 Why?
Administration, Topical
1
2020
62
0.040
 Why?
Forkhead Transcription Factors
1
2021
120
0.040
 Why?
Urinary Bladder
1
2020
101
0.040
 Why?
Patient Selection
1
2020
273
0.040
 Why?
Treatment Failure
1
2019
119
0.040
 Why?
Macrophages
1
2021
380
0.030
 Why?
Socioeconomic Factors
1
2020
623
0.030
 Why?
Health Facilities
1
2017
40
0.030
 Why?
Oncolytic Virotherapy
1
2017
28
0.030
 Why?
Combined Modality Therapy
1
2018
640
0.030
 Why?
Adolescent
2
2019
6907
0.030
 Why?
Turkey
1
2015
17
0.030
 Why?
Mutation
1
2021
1337
0.030
 Why?
Clinical Trials as Topic
1
2017
466
0.030
 Why?
Child
2
2019
7379
0.030
 Why?
Graft Survival
1
2015
157
0.030
 Why?
Cytokines
1
2017
627
0.030
 Why?
Registries
1
2017
652
0.030
 Why?
Antibodies, Monoclonal
1
2017
477
0.030
 Why?
Mice
1
2020
5982
0.020
 Why?
Child, Preschool
1
2019
4162
0.020
 Why?
Young Adult
1
2018
4511
0.020
 Why?
United States
1
2017
5409
0.020
 Why?
Animals
1
2020
13526
0.010
 Why?
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (135) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department